Loading, please wait...
This CE activity was originally published in The Rx Consultant. If you received credit for it previously, you cannot receive credit for it againObesity is a serious health problem and a common diagnosis in the United States, affecting over 40% of adults and 20% of adolescents (12-19 years). Obesity-related conditions include heart disease, type 2 diabetes, osteoarthritis, hypertension, certain types of cancer, and dyslipidemia, among others. Patients with obesity have annual medical costs that are $1,429 greater than those of people with a non-obese body mass index (BMI).
Overall, this condition costs the US healthcare system over $147 billion annually. Long-term consequences for children with obesity include a greater likelihood of being obese as an adult and increased severity of obesity-related diseases in adulthood.As we learn more about obesity, there is an increasing interest in programs and treatments that help prevent its development and lessen its negative effects. This issue will focus on non-drug strategies for managing excess weight, FDA-approved medications for the treatment of obesity, and factors that influence weight gain, including medications used for the treatment of chronic diseases.
Fee
$10.00
CE Hours
1.50
CE Units
0.150
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists, Nurse Practitioners, Clinical Nurse Specialists, and Registered Nurses
Accreditation(s)
This CE activity was developed by The Rx Consultant, a publication of Continuing Education Network, Inc.
CE activities for Pharmacists and Pharmacy Technicians: This continuing education (CE) activity meets the requirements of all state boards of pharmacy for approved continuing education hours. CE credit is automatically reported to CPE Monitor. CE activities for Nurse Practitioners and Clinical Nurse Specialists:
This continuing education activity meets the requirements of:
The American Nurses Credentialing Center (ANCC) for formally approved continuing education (CE) hours, and CE hours of pharmacotherapeutics. The American Academy of Nurse Practitioners Certification Program (AANPCP) for acceptable, accredited CE. This is a pharmacotherapeutics/pharmacology CE activity.
|
|
|
Continuing Education Network, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Requirements for CE Credit
To receive CE credit, the participant must read the monograph in its entirety, complete the online post-test and receive a score of 70% or greater, and complete the online evaluation.
Pharmacists and Pharmacy Technicians -
Be sure your profile has been updated with your NAPB e-profile # and birth date information BEFORE completing the online evaluation, or your credits cannot be reported to CPE Monitor.
Continuing pharmacy education credit is automatically reported to CPE Monitor once the post-test & evaluation are successfully completed.
Objectives
- Define overweight and obesity and the potential health benefits of losing excess weight.
- Identify FDA approved medications to consider for weight management based on individual patient characteristics. Describe benefits and risks of these medications, including side effects and drug interactions.
- Identify medications that are used for chronic conditions that may impact weight gain or weight loss.
Speaker(s)/Author(s)
|
Kylee A. Funk, PharmD, BCPS Brief Bio : is an Associate Professor at the University of Minnesota College of Pharmacy. In this role, she is a co-course director for the Diabetes and Metabolic Syndrome course and also provides patient care in primary care. |
|
|
Lauren T. Bloch, PharmD Brief Bio : is a clinical pharmacist practicing Medication Therapy Management at the M Health Fairview Comprehensive Weight Management Clinic in Minneapolis, Minnesota. |
Activity Number
0428-0000-20-006-H01-P
Release Date:
Jun 22, 2020
Credit Expiration Date:
Jun 22, 2023
CE Hours
1.50
Fee
$10.00
The CE Activity developed by The Rx Consultant